Abstract
Propranolol and isosorbide-5-mononitrate (ISMN) are increasingly used in the prophylaxis of variceal haemorrhage in cirrhosis. However, recent studies have suggested that these drugs may compromise renal function, possibly by reducing renal blood flow. To assess the acute effects of propranolol and ISMN on renal blood flow and other haemodynamic parameters in cirrhosis. Twenty six cirrhotic patients were given either 80 mg propranolol, 20 mg ISMN, or a combination of the two drugs. Unilateral renal blood flow (RBF), azygos blood flow (AZBF), hepatic venous pressure gradient (HVPG), mean arterial pressure (MAP), and heart rate (HR) were recorded prior to and one hour after drug administration. Propranolol caused a reduction in HR (p < 0.005), AZBF (p < 0.01), and HVPG (p = 0.05), but no change in MAP or RBF (454.1 (77.3) versus 413.9 (60.3) ml/min). ISMN reduced MAP (p < 0.005) and HVPG (p < 0.01), but had no effect on HR, AZBF, or RBF (302.5 (49.4) versus 301.7 (58.8) ml/min). Combined treatment reduced MAP (p < 0.005), AZBF (p < 0.05), and HVPG (p = 0.002), but HR and RBF (419.2 (62.6) versus 415.1 (61.1) ml/min) remained unchanged. Despite the anticipated changes in other haemodynamic parameters, acute propranolol and/or ISMN...Continue Reading
References
Nov 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H HenriksenT I Sørensen
Jan 1, 1992·European Journal of Clinical Pharmacology·N LjubicićV Plavsić
Mar 1, 1992·Gut·P C HayesH M Brash
May 30, 1991·The New England Journal of Medicine·T PoynardD Lebrec
Jul 21, 1990·Lancet·P C HayesI A Bouchier
May 15, 1991·Annals of Internal Medicine·J C García-PagánJ Rodés
May 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H O ConnM Navasa
Sep 1, 1990·Journal of Hepatology·J C García-PagánJ Rodés
Jul 1, 1990·Chest·M BrennerJ E Parrillo
May 1, 1989·Journal of Hepatology·M BernardiG Gasbarrini
Oct 1, 1987·The New England Journal of Medicine·J P Pascal, P Cales
Apr 1, 1987·Journal of Hepatology·C MerkelA Gatta
Jan 1, 1986·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G Garcia-TsaoJ L Alberts
Jan 1, 1971·Nephron·A HornychV Slechta
Mar 1, 1982·Drugs·R Wilkinson
Nov 10, 1984·Lancet·P C HayesI A Bouchier
Sep 1, 1984·Archives of Internal Medicine·W G Rector, T B Reynolds
Jul 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G D'AmicoJ Bosch
Sep 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C MerkelG Sebastianelli
Dec 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R M MorillasM A Gassull
Apr 1, 1994·Scandinavian Journal of Gastroenterology·G BertoniD Pacchione
Sep 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H Henriksen, H Ring-Larsen
Sep 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J VorobioffL Pozzoli
May 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M SalmerónV Arroyo
May 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F SalernoR deFranchis
Feb 1, 1997·Journal of Hepatology·B BernardT Poynard
Citations
Jan 14, 2010·Inflammopharmacology·Omar Mohamed E Abdel SalamNermeen Shafee
Aug 15, 2002·Journal of Hepatology·Gianmario BorroniRoberto de Franchis
Nov 4, 2000·Journal of Gastroenterology and Hepatology·S D ChenW Y Lin
Apr 1, 1999·The New England Journal of Medicine·A K Burroughs, D Patch
Nov 22, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Aleksander KragFlemming Bendtsen
Oct 30, 2016·Disease-a-month : DM·Eula Plana TetangcoEdgar V Lerma
May 1, 2001·Alimentary Pharmacology & Therapeutics·A Helmy, P C Hayes